Posts

Showing posts from August, 2019

BICELTIS - 440MG

Image
                      Anti Cancer Drug-BICELTIS - 440MG  PRODUCT DETAILS: Brand name : Biceltis  Composition : Trastuzumab  Strength : 440mg  Manufactured by : Emcure  Pack : two vials in a container; one vial containing drug                                                                                    Trastuzumab 1.0ml& one vial containing bacteriostatic water. Description: Biceltis 440mg is a group of medicines which belongs to anti neoplastic medication.  Biceltis 440mg  is a chemotherapy drug. It is recommended that  Biceltis 440mg  be administered under the guidance of a qualified physician experienced in the use of cancer chemotherapeutic agents. USES The injection  Biceltis 440mg  is used alone or combination with other medicine for the treatment in patients who suffering from metastatic breast cancer. The drug also indicated with combination of other medicine for the treatment of certain types of stomach or esophagus cancer in some persons. WORK AS

OLIMAB 60MG | My Apple Pharma

Image
                        Anti Cancer Drug-Olimab 60mg PRODUCT DETAILS Brand name : Olimab  Strength : 60mg Active substance : Denosumab  Manufactured by : Intas Pharmaceuticals  Pack : I injection in a prefilled syringe Description: Olimab 60mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides. PRESCRIBED: Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture. Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic

XTANDI 40MG | My Apple Pharma

Image
                     ANTI CANCER DRUG-XTANDI 40MG PRODUCT DETAILS Active ingredient : Enzalutamide  Strength : 40MG  Package : 28 capsules  Category : Anti-neoplastic agent Description: Xtandi is a hormonal therapy used for advanced prostate cancer treatment, like for 0men who are all affected with prostate carcinoma in metastatic stage. These are majorly indicated for prostate carcinoma, which contains Enzalutamide , as an active component considered as non steroidal anti-androgen medication. It is involved in association with castration in the therapy of metastatic or long lasting castration resistant prostate cancer. It is a prescribing medicine, the main ingredient which is used as enzalutamide ,only prescribed by medical oncologist. XTANDI DOSING CONDITIONS AND ADMINISTRATION The usual prescribed dosage of Xtandi is 160mg as a single dose by taking with or without food. Xtandi is available in the strength of 40mg; four Capsules of Xtandi should be administere

XGEVA 120MG| Myapplepharma

Image
                    Anti Cancer Drug-XGEVA 120MG PRODUCT DETAILS                                                                                     Brand Name : Xgeva  Composition : Denosumab  Strength availability : 120mg  Manufactured by : Dr. Reddy’s  Form : injection  Pack : I injection in a prefilled syringe Description: Xgeva 120mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides. PRESCRIBED FOR Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture. Treatment for patients with in

SECUKINUMAB | Myapplepharma

Image
                 Anti Cancer Drug-Scapho 150mg Injection PRODUCT DETAILS Composition : Secukinumab  Strength availability : 150mg  Form : injection  Pack : 150mg in 1 vial Description: Secukinumab Scapho 150mg belongs to monoclonal antibody which is a protein which recognises and connect to an inflammatory protein called Interleukin 17A (IL-17A). In patients with psoriatic arthritis and ankylosing spondylitis, the body’s immune system produces an increased amount of IL-17A which causes the symptoms such as swollen and painful joints  Scapho 150m  is a prescription drugs which is used under proper guidance of medical oncologist INDICATION Scapho 150m g indicated for the treatment of following condition Plaque Psoriasis Psoriatic arthritis Ankylosing spondylitis. DOSAGE Plaque Psoriasis: Starting dose: given 300 mg SC at weeks 0, 1, 2, 3, and 4 initially at week 8, administer 300 mg SC once monthly For some patientsmay be acceptable containing dose of 150 mg Ps

XOVOLTIB- 40MG | My Apple Pharma

Image
                        Anti Cancer Drug-Xovoltib 40mg PRODUCT DETAILS: Composition : Afatinib Strength availability : 40mg  Pack : 7 tablets in a strip Description: Xovoltib 40mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Xovoltib 40mg is a prescription drugs which is used under the guidance of medical practioners. INDICATION Xovoltib 40mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. DOSAGE: Xovoltib 40mg the prescribed dose for the treatment of non-small cell lung cancer as follows : For adult : The prescribed dose is 40mg taken once per day. For child dosage : Ages of 0-17 years is not being studied in children. The drug should not be used age under 18 years of age For renal impair

XOVOLTIB- 50MG | My Apple Pharma

Image
                         Anti Cancer Drug-Xovoltib 50mg PRODUCT DETAILS: Composition : Afatinib Strength availability : 50mg  Pack : 7 tablets in a strip Description: Xovoltib 50mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Xovoltib 50mg is a prescription drugs which is used under the guidance of medical practioners. INDICATION Xovoltib 50mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. DOSAGE: dosage Xovoltib 50mg the prescribed dose for the treatment of non-small cell lung cancer as follows : For adult : The prescribed dose is 40mg taken once per day. For child dosage : Ages of 0-17 years is not being studied in children. Xovoltib 50mg should not be used age under 18 years of age For

XOVOLTIB- 30MG | My Apple Pharma

Image
                         Anti-cancer Drug-Xovoltib 30mg PRODUCT DETAILS Composition : Afatinib Strength availability : 30mg  Pack : 7 tablets in a strip Description: Xovoltib 30mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Xovoltib 30mg is a prescription drugs which is used under the guidance of medical practioners. INDICATION Xovoltib 30mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. DOSAGE: Xovoltib 30mg the prescribed dose for the treatment of non-small cell lung cancer as follows : For adult : The prescribed dose is 40mg taken once per day. For child dosage : Ages of 0-17 years is not being studied in children. The drug should not be used age under 18 years of age For renal impairm

XOVOLTIB- 20MG | My Apple Pharma

Image
                                Anti-Cancer Drug Afatinib xovoltib: PRODUCT DETAILS: Ingredient : Afatinib Strength availability : 20mg  Pack : 7 tablets in a strip Description: Xovoltib 20mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Xovoltib 20mg is a prescription drugs which is used under the guidance of medical practioners. INDICATION: Xovoltib 20mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. DOSAGE: Xovoltib 20mg the prescribed dose for the treatment of non-small cell lung cancer as follows : For adult : The prescribed dose is 40mg taken once per day. For child dosage : Ages of 0-17 years is not being studied in children. The drug should not be used age under 18 years of age For

ROZEL 60MG-My Apple Pharma

Image
                           Anti Cancer Drug-Rozel 60mg Rozel 60mg: rozel 60mg PRODUCT DETAILS: Brand Name : Rozel  Composition : Denosumab  Strength availability : 60mg  Manufactured by : Intas pharmaceuticals  Form : injection  Pack : I injection in a prefilled syringe Description: Rozel 60mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides. PRESCRIBED FOR:  Rozel 60mg Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture. Treatment for patients with increase bone mass in men a

SECUKINUMAB 150MG

Image
                      Anti Cancer Drug-secukinimab 150mg Secukinimab(scapho) 150mg: scapho 150mg product details: Composition : Secukinumab Strength availability : 150mg Form : injection Pack : 150mg in 1 vial Description: Secukinumab belongs to monoclonal antibody which is a protein which recognises and connect to an inflammatory protein called Interleukin 17A (IL-17A). In patients with psoriatic arthritis and ankylosing spondylitis, the body’s immune system produces an increased amount of IL-17A which causes the symptoms such as swollen and painful joints Scapho 150mg is a prescription drugs which is used under proper guidance of medical oncologist INDICATION: Scapho 150mg indicated for the treatment of following condition Plaque Psoriasis Psoriatic arthritis Ankylosing spondylitis. DOSAGE: dosage Plaque Psoriasis: Starting dose: given 300 mg SC at weeks 0, 1, 2, 3, and 4 initially at week 8, administer 300 mg SC once monthly